The ESX-1 secretion system plays a critical role in the virulence of Mycobacterium tuberculosis and M. marinum. To date, three proteins are known to be secreted by ESX-1 and necessary for virulence, two of which are CFP-10 and ESAT-6. The ESX-1 secretion and the virulence mechanisms are not well understood. In this study, we have examined the M. marinum secretomes and identified four proteins specific to ESX-1. Two of those are CFP-10 and ESAT-6, and the other two are novel: MM1553 (homologous to Rv3483c) and Mh3881c (homologous to Rv3881c). We have shown that Mh3881c, CFP-10 and ESAT-6 are co-dependent for secretion. Mh3881c is being cleaved at close to the C-terminus during secretion, and the C-terminal portion is critical to the co-dependent secretion, the ESAT-6 cellular levels, and interaction with ESAT-6. The co-dependent secretion is required for M. marinum intracellular growth in macrophages, where the Mh3881c C-terminal portion plays a critical role. The role of the co-dependent secretion in intracellular growth correlates with its role in inhibiting phagosome maturation. Both the secretion and the virulence defects of the Mh3881c mutant are complemented by Mh3881c or its M. tuberculosis homologue Rv3881c, suggesting that in M. tuberculosis, Rv3881c has similar functions.

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1365-2958.2007.05959.xDOI Listing

Publication Analysis

Top Keywords

co-dependent secretion
16
cfp-10 esat-6
12
inhibiting phagosome
8
phagosome maturation
8
secretion
8
esx-1 secretion
8
plays critical
8
critical role
8
secretion virulence
8
esat-6 co-dependent
8

Similar Publications

PTPN23-dependent ESCRT machinery functions as a cell death checkpoint.

Nat Commun

November 2024

Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, NY, USA.

Cell death plasticity is crucial for modulating tissue homeostasis and immune responses, but our understanding of the molecular components that regulate cell death pathways to determine cell fate remains limited. Here, a CRISPR screen of acute myeloid leukemia cells identifies protein tyrosine phosphatase non-receptor type 23 (PTPN23) as essential for survival. Loss of PTPN23 activates nuclear factor-kappa B, apoptotic, necroptotic, and pyroptotic pathways by causing the accumulation of death receptors and toll-like receptors (TLRs) in endosomes.

View Article and Find Full Text PDF

Evasion of apoptosis promotes tumor survival and contributes to resistance to cancer therapeutics in head and neck squamous cell carcinoma (HNSCC). Our recent work has demonstrated that HNSCC's highly express pro-survival anti-apoptotic proteins Bcl-xL and Mcl-1. Nevertheless, the mechanism of HNSCC to evade apoptosis is still not well understood.

View Article and Find Full Text PDF

The events that control breast cancer progression and metastasis are complex and intertwined. Hypoxia plays a key role both in oncogenic transformation and in fueling the metastatic potential of breast cancer cells. Here we review the impact of hypoxia on epigenetic regulation of breast cancer, by interfering with multiple aspects of the tumour microenvironment.

View Article and Find Full Text PDF
Article Synopsis
  • - The direct Fick principle is used to calculate cardiac output (CO) to identify conditions like exercise pulmonary hypertension (ePH) by comparing arterial and mixed venous values, which can lead to inconsistencies based on the presence of an arterial catheter.
  • - A study analyzed 296 invasive cardiopulmonary exercise tests, revealing significant discrepancies in oxygen saturation and CO calculations between arterial and non-arterial methods, which resulted in a higher rate of data loss and misclassification of pre- and post-capillary ePH.
  • - The findings suggest that relying on non-arterial measures during exercise testing can misclassify ePH, particularly affecting patients with conditions like scleroderma, Raynaud's, and black individuals
View Article and Find Full Text PDF

BCL-xL and BCL-2 are validated therapeutic targets in small-cell lung cancer (SCLC). Targeting these proteins with navitoclax (formerly ABT263, a dual BCL-xL/2 inhibitor) induces dose-limiting thrombocytopenia through on-target BCL-xL inhibition in platelets. Therefore, platelet toxicity poses a barrier in advancing the clinical translation of navitoclax.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!